GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Xizang Weixinkang Pharmaceutical Co Ltd (SHSE:603676) » Definitions » Market Cap

Xizang Weixinkang Pharmaceutical Co (SHSE:603676) Market Cap : ¥4,025 Mil (As of Apr. 16, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Xizang Weixinkang Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Xizang Weixinkang Pharmaceutical Co's share price for the quarter that ended in Sep. 2024 was ¥9.04. Xizang Weixinkang Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 435 Mil. Therefore, Xizang Weixinkang Pharmaceutical Co's market cap for the quarter that ended in Sep. 2024 was ¥3,934 Mil.

Xizang Weixinkang Pharmaceutical Co's quarterly market cap declined from Mar. 2024 (¥3,651 Mil) to Jun. 2024 (¥3,486 Mil) but then increased from Jun. 2024 (¥3,486 Mil) to Sep. 2024 (¥3,934 Mil).

Xizang Weixinkang Pharmaceutical Co's annual market cap increased from Dec. 2021 (¥4,051 Mil) to Dec. 2022 (¥6,928 Mil) but then declined from Dec. 2022 (¥6,928 Mil) to Dec. 2023 (¥4,539 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Xizang Weixinkang Pharmaceutical Co's Enterprise Value for Today is ¥3,051 Mil.


Xizang Weixinkang Pharmaceutical Co Market Cap Historical Data

The historical data trend for Xizang Weixinkang Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xizang Weixinkang Pharmaceutical Co Market Cap Chart

Xizang Weixinkang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,488.03 3,802.77 4,050.71 6,927.78 4,538.74

Xizang Weixinkang Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,747.62 4,538.74 3,651.01 3,485.65 3,933.86

Competitive Comparison of Xizang Weixinkang Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Xizang Weixinkang Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xizang Weixinkang Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Xizang Weixinkang Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Xizang Weixinkang Pharmaceutical Co's Market Cap falls into.


;
;

Xizang Weixinkang Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Xizang Weixinkang Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥10.43*435.162
=¥4,539

Xizang Weixinkang Pharmaceutical Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=¥9.04*435.162
=¥3,934

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xizang Weixinkang Pharmaceutical Co  (SHSE:603676) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Xizang Weixinkang Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Xizang Weixinkang Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Xizang Weixinkang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Yuanqu South Road, 3rd Floor, Building 4, Industrial Center, No. 5, Zone B, Lhasa Economic and Technological, Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000
Xizang Weixinkang Pharmaceutical Co Ltd is engaged in research & development, production and sales of chemical pharmaceutical preparations and their raw materials. It also produces and sells liver protection drugs and antibiotic products.
Executives
Weng Zi Zhong senior management
Chen Shi Gong Directors, senior managers
Zhou Xiao Bing senior management
Liu Feng Directors, senior managers
Yu Hai Bo senior management
Zhang Hong Directors, senior managers
Zheng Yan Xia senior management
Wen Xiao Quan Director

Xizang Weixinkang Pharmaceutical Co Headlines

No Headlines